The National Quality Forum (NQF) has endorsed a performance measure designed to increase imaging efficiency for the evaluation of pulmonary embolism (PE) in the emergency department (ED). To our knowledge, no published data have examined the effect of patient-level predictors on performance.
A PPROXIMATELY 120 MILlion patients present each year to US emergency departments (EDs), 1 of whom 1.5% undergo computed tomography (CT) of the pulmonary arteries (CTPA) to evaluate for pulmonary embolism (PE). 2 Despite evidence that structured diagnostic pathways can safely exclude PE without imaging, there has been poor application of clinical decision rules in the ED. [3] [4] [5] [6] As a result, imaging for PE may be overused. 4, 5, [7] [8] [9] with potentially negative cost and health consequences. [10] [11] [12] [13] In 2011 the National Quality Forum (NQF) endorsed an imaging efficiency measure directed at the appropriateness of CTPA use in ED patients with low pretest probability (PTP) of PE. 14, 15 Based on retrospective data, the NQF estimated that 7% to 25% of imaging studies are avoidable. 14 However, prospective data are required to assess imaging appropriateness and therefore, the potential for performance improvement. The goal of this study was to quantify the "performance gap" based on the NQF measure.
METHODS

DESIGN AND SETTING
We analyzed a prospective, multicenter, observational study of ED patients undergoing testing for suspected PE. Patients were enrolled at 12 US hospitals (10 academic and 2 community hospitals) from July 2003 through March 2007. The methods of this study have been described previously. 2 The institutional review board of each institution approved the protocol.
POPULATION
Eligible ED patients had an order for an objective diagnostic test (D-dimer, CTPA, ventilation/perfusion scan [V/Q], or pulmonary angiogram), written under supervision of a boardcertified emergency physician to evaluate possible PE.
2 Patients were enrolled consecutively or during randomly assigned shifts representative of all ED shifts. 2 For this analysis, we included patients enrolled at hospitals using a high-sensitivity, quantitative D-dimer and with multidetector spiral CT available to the ED. Cutoffs used to define positive tests were institutionally determined, as previously described. 16 After a diagnostic test for PE was ordered, but before results were known, we prospectively collected 74 data points, including the objective elements of the Wells score by interviewing the patient and reviewing the medical record. 17 We also asked the clinician ordering the initial trigger test to provide their most likely diagnosis and gestalt PTP. We classified gestalt PTP as low (Ͻ15%), medium (15%-40%), or high (Ͼ40%). This was a noninterventional study, so all diagnostic decisions were made by the treating physician with data available in the ED.
We excluded patients in whom the treating physician had knowledge of a positive imaging study for PE within 7 days and patients being evaluated for deep vein thrombosis without PE.
OUTCOMES
The primary outcome was avoidable imaging, defined as either CTPA or V/Q in hemodynamically stable (systolic blood pressure Ն90 mm Hg) patients with low PTP (Wells score Ͻ2), 18 and in whom D-dimer testing was either not done or the Ddimer result was negative. While the NQF measure is specific
COMMENT
Rising health care costs from advanced imaging and improved understanding of the risks associated with ionizing radiation and intravenous contrast are driving efforts to improve imaging efficiency. To our knowledge, our analysis is the first to quantify imaging appropriateness for PE, we found that 1 in 3 ED imaging studies (33%) was potentially avoidable. This "performance gap" persisted whether we assessed all imaging or CTPA alone and when PTP cutoffs were varied.
Our study is unique in that our prospective assessment of PTP, and our enrollment of patients regardless of imaging use enabled us to assess imaging appropriateness, rather than imaging utilization, as estimated by previous retrospective studies. 5 Failure to perform D-dimer testing was responsible for nearly two-thirds of potentially avoidable imaging studies. This phenomenon may be explained by physician bias toward more "definitive" testing with CTPA, use of CTPA for evaluation of possible non-PE alternative diagnoses, overestimation of expected D-dimer testing false-positivity, or underestimation of D-dimer testing sensitivity. It could also be explained by physician overestimation of gestalt PTP. However, our subanalysis does not support this. Figure. Application of the National Quality Forum pulmonary embolism (PE) imaging efficiency measure. Pretest probability is based on the Wells score: low pretest probability, less than 2 points; intermediate pretest probability, 2 to 6 points; high pretest probability, more than 6 points. All percentages were calculated using the number of hemodynamically stable (systolic blood pressure Ն90 mm Hg) patients who underwent workup for PE with imaging as the denominator. We found few patient-level predictors of avoidable imaging. This suggests that imaging inefficiency is likely to be more related to variation in physician-level risk tolerance, patient preference, or hospital characteristics not measured by our study. Future work in this area will be valuable. Age, pregnancy, and sickle cell disease, factors known to be associated with positive D-dimer test results, were predictive of avoidable imaging owing to no D-dimer test being performed. 16 Clinicians may have bypassed D-dimer testing in these patients, anticipating positive results. Further research is needed to determine whether patients in whom D-dimer specificity is low may be suitable for measure exclusion. Imaging performed following a negative D-dimer test result in patients with inactive cancer may represent an opportunity for quality improvement, because clinicians may overestimate the risk of PE in these patients. 16, 21 Our results demonstrate the validity of the NQF measure and refute the notion that high measure performance is associated with the unintended consequence of missed PE. Assuming 100% imaging specificity, measure adherence would have resulted in 11 "missed" PEs: 8 patients with a negative D-dimer test result and 3 patients who would have undergone D-dimer testing [93% sensitivity] testing according to the guideline. 22 Several considerations in the interpretation of our results warrant mention. Consistent with the NQF guideline, we report potentially avoidable, as opposed to definitely avoidable, imaging for patients with no D-dimer testing performed. All patients were enrolled in hospitals participating in PE research. Such hospitals may be more likely to follow clinical guidelines, so our results may underestimate avoidable imaging. We also recognize that some CTPA may have been ordered to evaluate alternative diagnoses in addition to PE. Abbreviations: CTD, connective tissue disease; NP, no patients in these categories; OR, odds ratio. a Low pretest probability is consistent with the definition used in the NQF-endorsed measure (Wells score Ͻ2). b Statistically significant based on 95% CIs not crossing unity. c Active cancer includes malignant disease being actively treated or palliated.
ARCH INTERN MED/ VOL 172 (NO. 13), JULY 9, 2012 In summary, we found that one-third of ED imaging studies for suspected PE are potentially avoidable. The opportunity for improving the efficiency of imaging for suspected PE is large. Future work should focus on interventions to close this performance gap.
